(RTTNews.com) - Today's Daily Dose brings you news about Akari and Ignyta's public offering; Conatus' drug candidate securing orphan designation from the European Medicines Agency; FDA approval of Gilead's CAR-T therapy for refractory large B-cell ...
SEATTLE—Thursday is the deadline for cities bidding to host “HQ2,” as Amazon calls its planned second headquarters, and the competition has been intense.
American Express Co.'s Ken Chenault is (finally, some would say) retiring. The timing isn't bad. Saving Face. Ken Chenault's legacy has been saved in part by the rally in U.S.
Business television commentator and Swiss investor Marc Faber is facing backlash for racist comments in the October edition of his "Gloom, Boom & Doom Report.
Ford Motor Co. may be both flush with cash and struggling with its stock price, but new chief executive officer Jim Hackett is in no rush to buy Wall Street's love.